Asbestosis and Idiopathic Pulmonary Fibrosis: Comparison of Thin-Section CT Features 1

Size: px
Start display at page:

Download "Asbestosis and Idiopathic Pulmonary Fibrosis: Comparison of Thin-Section CT Features 1"

Transcription

1 Thoracic Imaging Radiology Susan J. Copley, MD, MRCP, FRCR Athol U. Wells, MD, FRACP Pathanamathan Sivakumaran, MBBS, FRACP Michael B. Rubens, MB, DMRD, FRCR Y. C. Gary Lee, MBChB, PhD, FRACP Sujal R. Desai, MD, MRCP, FRCR Sharyn L. S. MacDonald, MBChB Richard I. Thompson, MBBS, FRACR Thomas V. Colby, MD Andrew G. Nicholson, MRCPath, DM Roland M. du Bois, MA, MD, FRCP A. William Musk, MD, FRACP David M. Hansell, MD, FRCP, FRCR Index terms: Asbestos Lung, CT, , , Lung, diseases, , , , , Lung, fibrosis, , Pneumonia, interstitial with fibrosis, , Published online before print /radiol Radiology 2003; 229: Abbreviations: IPF idiopathic pulmonary fibrosis NSIP nonspecific interstitial pneumonia UIP usual interstitial pneumonia 1 From the Dept of Radiology, Hammersmith Hosp, London, England (S.J.C.); Dept of Radiology, King s College Hosp, London, England (S.R.D.); Depts of Radiology (S.L.S.M., D.M.H., M.B.R.) and Pathology (A.G.N.), and Interstitial Lung Disease Unit (A.U.W., R.M.d.B.), Royal Brompton Hosp, Sydney St, London SW3 6NP, England; Depts of Radiology (R.I.T.) and Respiratory Medicine (A.W.M.), Sir Charles Gairdner Hosp, Perth, West Australia, Australia; Dept of Respiratory Medicine, Middlemore Hosp and Univ of Auckland, New Zealand (P.S.); and Dept of Laboratory Medicine/Pathology, Mayo Clinic, Scottsdale, Ariz (T.V.C.). Received Jun 4, 2002; revision requested Aug 8; final revision received Apr 30, 2003; accepted Jun 16. Address correspondence to D.M.H. ( d.hansell@rbh.nthames.nhs.uk). Author contributions: Guarantor of integrity of entire study, D.M.H.; study concepts and design, S.J.C., D.M.H., A.U.W.; literature research, S.J.C.; clinical studies, A.U.W., A.W.M.; data acquisition, S.J.C., S.R.D., S.L.S.M.; data analysis/interpretation, all authors; statistical analysis, A.U.W.; manuscript preparation, editing, and final version approval, S.J.C., D.M.H., A.U.W.; manuscript definition of intellectual content, D.M.H., A.U.W.; manuscript revision/review, all authors RSNA, 2003 Asbestosis and Idiopathic Pulmonary Fibrosis: Comparison of Thin-Section CT Features 1 PURPOSE: To identify differences, if any, in thin-section computed tomographic (CT) features between asbestosis and idiopathic pulmonary fibrosis (IPF) and to test the findings in a subset of histopathologically proved cases of usual interstitial pneumonia (UIP) and nonspecific interstitial pneumonia (NSIP). MATERIALS AND METHODS: Consecutive patients with a diagnosis of IPF (n 212) or asbestosis (n 74) were included. The relationships derived from the initial comparison were tested in a separate group of biopsy-proved UIP (n 30) and NSIP (n 23) cases. Two observers independently scored thin-section CT images for extent, distribution, and coarseness of fibrosis; proportion of ground-glass opacification; severity of traction bronchiectasis; and extent of emphysema. RESULTS: After controlling for extent of fibrosis, patients with asbestosis had coarser fibrosis than those with IPF (odds ratio, 1.52; 95% CI: 1.25, 1.84; P.001). Compared with the biopsy-proved cases, the asbestosis cases involved coarser fibrosis (after controlling for disease extent) than the NSIP cases (odds ratio, 2.48; 95% CI: 1.49, 4.11; P.001) but fibrosis similar to that in the UIP cases. A basal and subpleural distribution of disease was usual in all subgroups but significantly more prevalent (P,.01 to.001) with asbestosis than with UIP or NSIP. CONCLUSION: The thin-section CT pattern of asbestosis closely resembles that of biopsy-proved UIP and differs markedly from that of biopsy-proved NSIP. RSNA, 2003 The imaging features of asbestos-induced pulmonary fibrosis, or asbestosis, and idiopathic pulmonary fibrosis (IPF) are, at first sight, similar. Common thin-section computed tomographic (CT) features are a subpleural reticular pattern, honeycombing, and ground-glass opacification, which affect predominantly the posterobasal regions of the lungs (1). In general, emphasis has been placed on the presence or absence of pleural involvement (ie, pleural plaques or diffuse pleural thickening) in discriminating between asbestosinduced pulmonary fibrosis and IPF (2). However, relying on pleural disease alone may be an oversimplified way to differentiate these two entities: An individual previously exposed to asbestos is as susceptible to the same non asbestos-induced fibrotic lung diseases (including IPF) as the general population (2), and diffuse pleural thickening may be due to other causes. Histopathologically, asbestosis and IPF have similar features. Both individuals with usual interstitial pneumonia (UIP) and those with nonspecific interstitial pneumonia (NSIP) may have clinical findings of IPF. With asbestosis, the fibrosis is typically patchy and closely resembles that with UIP (3). However, despite histopathologic similarities, the etiologies and biologic behaviors of the two conditions are different (2). Important issues, such as differences in prognosis and eligibility for legal or state compensation for asbestosis, highlight the need for accurate differentiation whenever possible (2). The aim of the present study was to identify differences, if any, between the thin-section CT morphologic features of asbestosis and those of IPF and to test the findings in a subset of histopathologically proved cases of UIP and NSIP. 731

2 MATERIALS AND METHODS Consecutive patients with asbestos exposure induced interstitial fibrosis that was seen on CT scans between January 1991 and February 1999 were identified from the hospital radiology database systems of two referral centers: Sir Charles Gairdner Hospital and Royal Brompton Hospital. Fifty-one cases of fibrosis were identified from Sir Charles Gairdner Hospital, and 36 were identified from Royal Brompton Hospital. Thirteen cases from Sir Charles Gairdner Hospital were excluded because of poor-quality images (ie, owing to motion artifact and/or inappropriate window levels). All of the remaining cases from this center (n 38) were those of asbestos miners. The other cohort of patients (n 36) had worked in a variety of asbestos-related industries. All cases (n 74) were diagnosed as asbestosis by an experienced occupational chest physician on the basis of clinical and radiologic criteria, an unequivocal history of substantial asbestos exposure, and an appropriate time between exposure and onset of symptoms, according to American Thoracic Society criteria for the diagnosis of asbestosis (4). Consecutive patients who were referred to the Interstitial Lung Disease Unit of Royal Brompton Hospital between 1991 and 1997 were identified from the hospital patient information system. Two hundred twelve patients with a diagnosis of IPF were included in this study. Patients with a diagnosis of IPF met the following clinical, physiologic, and radiographic criteria: (a) widespread persistent inspiratory crackles at auscultation, (b) a restrictive ventilatory defect and/or an isolated depression of gas transfer, (c) the presence of widespread persistent bilateral radiographic abnormalities consistent with IPF, and (d) no history of exposure to fibrogenic dusts or drugs (5). Patients with pulmonary fibrosis secondary to a connective tissue disease were excluded. On the basis of findings in a cohort examined in a previous study (6), consecutive patients who received a lung biopsy based (open or video-assisted thoracoscopic) diagnosis of UIP or NSIP between January 1990 and March 2000 were identified and examined separately (7,8). Of these patients, 53 who underwent thin-section CT 12 months before or after biopsy (median interval, 2 months) and met the described clinical criteria for the diagnosis of IPF were included in the study. Thirty of these patients had UIP and 23 NSIP. Patients with a connective tissue disease were again excluded. One of several authors (S.J.C., S.R.D., Y.C.G.L., S.L.S.M.) obtained demographic data (ie, age and sex) and smoking histories by independently reviewing patient records. Institutional review board approval and informed patient consent for retrospective review of patient records and images were not required at either center. Histopathologic Diagnosis All biopsy results were independently reviewed by two pathologists (A.G.N., T.V.C.). For the histopathologic diagnosis of UIP in 30 patients, the following criteria had to be met: evidence of temporal heterogeneity with nonuniform and variable interstitial changes, including intermingled zones of established interstitial fibrosis, inflammation, fibroblastic activity, honeycomb change, and normal lung parenchyma coexisting in variable proportions (9). NSIP was diagnosed when the fibrosis was either patchy or diffuse (primarily the latter), but the pattern of lung injury remained temporally uniform (10). When there was disagreement, the final diagnosis was reached by consensus. The 23 patients with a histopathologic diagnosis of NSIP were further separated into either predominantly cellular NSIP (n 5) or predominantly fibrotic NSIP (n 18) subgroups. Cellular NSIP was characterized by the presence of a mild to moderate chronic inflammatory cellular infiltrate within the interstitium, with either minimal or no interstitial fibrosis (10). Fibrotic NSIP was characterized by the presence of temporally homogeneous interstitial fibrosis, with or without derangement of the lung architecture, and an accompanying chronic inflammatory cellular infiltrate of varying intensity (10). In cases of disagreement, the final histopathologic diagnosis and grade of NSIP were determined by consensus. CT Scanning Protocol CT scanning was performed by using an electron-beam scanner (Imatron, San Francisco, Calif) or helical CT scanners (Somatom Plus, Siemens, Erlangen, Germany; or Toshiba Xpress, Toshiba, Tokyo, Japan), depending on the referral center. Thin (1 3-mm) sections were obtained at mm intervals in all patients, who were scanned in a supine position, prone position, or both. In the 212 patients with IPF, 1.5-mm sections were obtained in 121 patients and 3.0-mm sections were obtained in 91. In a proportion of the IPF cases, prone CT images were obtained; however, only the supine images (n 212) were evaluated by the observers. In all 53 patients with biopsy-proved UIP or NSIP, 1.5-mm sections were obtained. In the 74 patients with asbestosis, 1.0-mm sections were obtained in 38 patients; 1.5-mm sections, in 30; and 3.0-mm sections, in six. In 45 of these patients, prone images were obtained. All CT images were obtained at full suspended inspiration. The images were reconstructed with a high-spatial-frequency (ie, bone) algorithm and photographed at wide window settings (window level, 300 to 655 HU; window width, 1,500 1,850 HU), and all images were evaluated on film hard copies. Image Evaluation CT images were evaluated independently by two thoracic radiologists (D.M.H., M.B.R.), who were blinded to the clinical findings and pulmonary function data. Disagreements about the presence or absence of fibrosis (n 0) and emphysema (nine regarding asbestosis, two regarding IPF) were resolved by consensus. The images were scored at five levels: the great vessels, the aortic arch, the carina, the right inferior pulmonary vein, and halfway between the right inferior pulmonary vein and the caudal limit of the left costophrenic angle. The images were scored as follows: 1. At each level, the overall extent of pulmonary fibrosis, including the reticular pattern and ground-glass opacification with traction bronchiectasis, was visually estimated to the nearest 5%. The mean value (range, 0.5% to 100%) was considered the extent of fibrosis, irrespective of the predominant pattern. 2. At each level, the relative percentages of ground-glass opacification and the reticular pattern were recorded, and the extent of each was calculated as the proportion of each pattern multiplied by the overall disease extent. The proportion of ground-glass opacification was computed. Ground-glass opacification was defined as a hazy increase in attenuation, with preservation of the bronchial and vascular margins. A reticular pattern was defined as that of innumerable interlacing line shadows either fine, intermediate, or coarse with associated distortion of the lung architecture (11). 3. At each level, the coarseness of fibro- 732 Radiology December 2003 Copley et al

3 TABLE 1 Demographic Data and Smoking Histories of Study Patients Characteristic IPF (n 212) sis was assigned a grade of 0, indicating ground-glass opacification with no reticular element or cysts; 1, indicating predominantly fine intralobular fibrosis without cysts; 2, indicating a predominantly microcystic reticular pattern (ie, definable airspaces smaller than 3 mm in diameter); or 3, indicating a predominantly macrocystic reticular pattern (ie, airspaces larger than 3 mm in diameter). The scores for the five regions were summed to provide an overall coarseness score (range, 0 15). In cases in which no disease was seen on one or more CT sections, the coarseness score was adjusted proportionately to a five-level score to prevent spurious reductions in the coarseness score due to a localized distribution of disease. For example, in a patient with disease in only three of five sections, a coarseness score of 5 would be adjusted by 5/3 to At each level, the extent of emphysema was visually estimated to the nearest 5%. The mean value (range, 1% 100%) was considered the extent of emphysema. Emphysema was defined as an area of decreased attenuation, usually without discrete walls and with a nonuniform distribution causing permeative destruction of the lung parenchyma (11). UIP (n 30)* 5. At each level, the severity of bronchial dilatation within a reticular pattern or ground-glass opacification (traction bronchiectasis or bronchiolectasis) was graded by comparing the diameter of the airway with the diameter of the adjacent pulmonary artery: 0 meant no; 1, mild; and 2, severe dilatation. The five scores were summed to yield an overall traction bronchiectasis score (range, 0 10). 6. In the cases of asbestosis and biopsyproved UIP or NSIP, all CT sections were reviewed and the distribution of fibrosis was determined by consensus to be random, subpleural, bronchocentric, and/or basal. 7. In cases of asbestosis and IPF, the presence of pleural plaques and diffuse pleural thickening was recorded. Diffuse pleural thickening was defined as a continuous sheet of pleural thickening, whereas pleural plaques were defined as circumscribed areas of pleural thickening with well-demarcated edges (12). Statistical Analysis NSIP Asbestosis (n 23) (n 74) Sex (M/F) 158/54 20/10 14/9 73/1 Median age (y) 64 (26 84) 54 (36 76) 53 (32 68) 67 (46 86) Nonsmokers 44 (21) 10 (33) 8 (35) 10 (14) Smokers 161 (76) 18 (60) 13 (57) 56 (76) No smoking data 7 (3) 2 (7) 2 (9) 8 (11) Note. Unless otherwise noted, data are numbers of patients and numbers in parentheses are percentages. * Biopsy-proved UIP. Biopsy-proved NSIP. Numbers in parentheses are age ranges. Smokers include both ex-smokers and current smokers. TABLE 2 Thin-Section CT Features in Patients with IPF and Asbestosis CT Features IPF Group (n 212) Asbestosis Group (n 74) P Value Presence of emphysema* 76/212 (36) 25/74 (34) NS Emphysema extent (%) 10.5 ( ) 24.5 ( ).001 Fibrosis extent (%) 55 (5 96) 26 ( ).001 Fibrosis coarseness grade 9 (1 15) 9.5 ( ) NS Proportion of GGO 0.13 (0 0.81) 0.13 (0 0.70) NS Traction BRONC score 3.75 (0 9) 1 (0 8.5).001 Note. Unless otherwise noted, data are median values, with ranges in parentheses. * Data are numbers of patients and numbers in parentheses are percentages. BRONC bronchiectasis, GGO ground-glass opacification, NS not statistically significant. Results are expressed as means with SDs or medians with ranges (for non normally distributed variables). Group comparisons of continuous variables were performed with data analysis software (Stata; Computing Resource Centre, Santa Monica, Calif) by using the Student t or Wilcoxon rank sum test, depending on the data distribution. Differences in proportions were tested by using 2 statistics. Univariate correlations were examined by using Spearman correlation coefficients (ie, r s values). Observer variation was evaluated by using the weighted coefficient for semicategorical variables (13) or the single-determination SD for quantitative data (14). Independent differences in CT features between diseases were identified by using stepwise logistic regression. The extent of fibrosis, extent of emphysema, coarseness of fibrosis, proportion of groundglass opacification, severity of traction bronchiectasis, and distribution of fibrosis were included as covariates. Variables were retained in logistic regression models if they contributed to the explanatory power of the regression equation (P.10). RESULTS The demographic data on the 212 patients with IPF, 74 patients with asbestosis, and 53 patients with biopsy-proved UIP or NSIP are summarized in Table 1. The patients with asbestosis (n 74) were predominantly male (n 73), reflecting occupational exposure. There were significant differences (P.001) in sex between the asbestosis and IPF groups, between the UIP and asbestosis groups, and between the NSIP and asbestosis groups. There was no significant difference in age between the asbestosis and IPF groups, but the group with asbestosis was older overall than the UIP and NSIP groups (P.001). Across the four groups, the prevalence of nonsmokers was only marginally higher in the patients with biopsy-proved UIP and NSIP (P.05). Interobserver agreement between pathologists in discriminating between UIP and NSIP was fair (weighted coefficient, 0.57). Asbestosis versus IPF The CT features of the 212 patients with IPF and the 74 with asbestosis are summarized in Table 2. For the combined group of 286 patients, interobserver variation, expressed as the single-determination SD, was 7.4% for extent of fibrosis and 4.9% for proportion of ground-glass opacification. The weighted coefficient for interobserver agreement of coarseness of fibrosis was Among the 212 patients with IPF, fi- Volume 229 Number 3 CT Features of Asbestosis and Idiopathic Pulmonary Fibrosis 733

4 brosis was depicted in all cases; emphysema, in 76 (36%) cases; diffuse pleural thickening, in four (2%) cases; and pleural plaques, in no cases. In the asbestosis group, fibrosis was depicted in all 74 cases; emphysema, in 25 (34%) cases; pleural plaques, in 58 (78%) cases; and diffuse pleural thickening, in 61 (82%) cases. Forty-nine (66%) of the 74 patients with asbestosis had both pleural thickening and pleural plaques; four (5%) patients had no pleural disease. As shown in Table 2, fibrosis was more extensive in the IPF group (55%; range, 5% 96%) than in the asbestosis group (26%; range, 0.5% 90.5%) (P.001) (Table 2). The prevalence of emphysema did not differ significantly between the asbestosis and IPF groups, but the extent of emphysema was significantly greater in the asbestosis group (P.001). Traction bronchiectasis scores were higher in the IPF group (before adjustment for extent of fibrosis in multivariate analysis). Relationships between the extent of fibrosis and other CT features are summarized in Table 3. Strong correlations were seen between traction bronchiectasis scores and the extent of fibrosis in the asbestosis (r s 0.81, P.001) and IPF (r s 0.72, P.001) groups. Increasing coarseness scores and decreasing proportions of ground-glass opacification were more closely linked to increasing disease extent in the asbestosis group than in the IPF group. A logistic regression model was used to identify the CT features that differed independently between the IPF and asbestosis groups. After adjustment for age, sex, and extent of fibrosis, the patients with asbestosis were shown to have coarser fibrosis (odds ratio, 1.52; 95% CI: 1.25, 1.84; P.001). This finding was independent of the proportion of ground-glass opacification, the extent of emphysema, and traction bronchiectasis scores, none of which differed independently between the asbestosis and IPF groups. Asbestosis versus Biopsy-proved UIP At univariate analysis, fibrosis was more extensive in the UIP group than in the asbestosis group (46.6% 22.3 vs 28.0% 20.6, P.001). No single CT feature consistently enabled the differentiation between UIP and asbestosis. Coarseness scores and proportions of ground-glass opacification did not differ significantly between the UIP and asbestosis groups (before adjustment for disease extent in multivariate analysis). The TABLE 3 Univariate Correlations between CT Extent of Fibrosis and Other CT Features Correlation r s Value P Value Asbestosis group Coarseness vs extent Traction BRONC score vs extent Proportion of GGO vs extent IPF group Coarseness vs extent Traction BRONC score vs extent Proportion of GGO vs extent 0.13 NS Note. Coarseness and extent refer, respectively, to coarseness of fibrosis and extent of fibrosis. BRONC bronchiectasis, GGO ground-glass opacification, NS not statistically significant, r s Spearman rank correlation coefficient. distribution of fibrosis was basal and subpleural in the majority of patients, but it was more often basal in the asbestosis group in 72 (97%) of 74 patients versus 25 (83%) of 30 in the UIP group (P.01) and more often subpleural in the asbestosis group in 67 (91%) patients versus 20 (67%) in the UIP group (P.005). A bronchocentric distribution was seen in only two cases of UIP and was not seen with asbestosis. Examination of the logistic regression model revealed that after adjustment for age, sex, and extent of fibrosis, none of the CT features (ie, coarseness of fibrosis, proportion of ground glass opacification, extent of emphysema, traction bronchiectasis scores, and presence of a subpleural or basal distribution) differed significantly between the patients with asbestosis and those with biopsy-proved UIP. Asbestosis versus Biopsy-proved NSIP At univariate analysis, fibrosis was marginally more extensive in the NSIP group than in the asbestosis group (37.9% 23.4 vs 28.0% 20.6, P.05). There were significant differences in most CT features between the asbestosis and NSIP groups. The asbestosis cases, as compared with the NSIP cases, were characterized by higher coarseness scores (P.001) (Figure), a lower proportion of groundglass opacification (P.001), and higher likelihoods of basal (in 72 [7%] of 74 vs 16 [70%] of 23 patients, P.001) and subpleural (in 67 [91%] of 74 vs 14 [61%] of 23 patients, P.001) distributions. A bronchocentric distribution was not seen with NSIP. Examination of the logistic regression model revealed that after adjustment for age, sex, and extent of fibrosis, asbestosis was characterized by higher coarseness scores (odds ratio, 2.48; 95% CI: 1.49, 4.11; P.001). These relationships were independent of the proportion of ground-glass opacification, the extent of emphysema, and the distribution of disease, none of which differed independently between the asbestosis and NSIP groups. Univariate and multivariate logistic analyses were repeated in the comparison of the asbestosis and fibrotic NSIP groups, with five cases of cellular NSIP excluded. All findings at both univariate analysis and multivariate analysis remained statistically significant. DISCUSSION Our study results show a significant difference in thin-section CT coarseness of fibrosis between individuals with IPF and those with asbestosis. After controlling for the extent of fibrosis, we observed coarser fibrosis in the asbestosis group than in the IPF group. This observation was confirmed in a subset of biopsyproved NSIP cases after controlling for extent of fibrosis, extent of emphysema, and other CT features but there was no statistically significant difference in coarseness of fibrosis between the asbestosis and biopsy-proved UIP groups. Despite the convention that patients with IPF will have UIP at histopathologic examination of lung biopsy specimens (15), the clinical diagnosis of IPF (ie, that based on clinical criteria and compatible radiographic features) necessarily includes NSIP as well as UIP. Therefore, a difference in the coarseness of fibrosis between asbestosis and NSIP groups will also extend to the combined IPF group, but not when the analysis is confined to biopsy-proved UIP. Our study findings confirm that asbestosis resembles UIP but is strikingly different from NSIP. Our observations are in 734 Radiology December 2003 Copley et al

5 Transverse thin-section CT images show examples of the coarser fibrosis seen with (a) asbestosis (prone image), as compared with the fibrosis seen with (b) biopsy-proved NSIP. (a) Note the bilateral diffuse pleural thickening with asbestosis (arrows) and the extensive coarse, macrocystic reticular pattern consisting of definable airspaces larger than 3 mm in diameter (scored by both observers). (b) In contrast, both observers judged the patient with NSIP to have predominantly fine intralobular fibrosis; note the traction bronchiectasis (arrow). agreement with histopathologic data in that asbestosis and IPF have been reported to have similar appearances, with the exception that asbestos or ferruginuous bodies are present with asbestosis (3,16). Histopathologically, the fibrosis with asbestosis is typically patchy and has been described as closely resembling the UIP subtype that characterizes IPF (3). Virtually all of the patients with asbestosis in our study had a subpleural and basal distribution of fibrosis. This finding is in agreement with the observations made by Akira et al regarding patients with early asbestosis; they found that the small subpleural dots that became more confluent on subsequent CT images correlated histopathologically with subpleural fibrosis (17). The distribution of abnormalities on CT images is probably due to the fact that asbestos fibers are deposited in the small airways in the lung periphery, where they first elicit an inflammatory response. In the current study, the patients with asbestosis also had less extensive fibrosis than did those with IPF. One explanation for this discrepancy is some form of selection bias. The asbestosis cases were selected on the basis of CT reports, whereas the IPF cases were selected by using a combination of clinical, radiographic, and physiologic criteria, with which the presence of more extensive fibrosis might be required. The discrepancy also may be due to the earlier detection of disease in individuals who are exposed to asbestos because of closer radiographic and clinical surveillance. Increased patient awareness of symptoms, due to potential legal or state compensation for asbestosis, may be another factor. However, the observed differences in the quality of fibrosis (ie, fine vs coarse) are robust despite these potential selection biases according to our results, which were controlled for the extent of fibrosis. Gaensler and Carrington first studied the correlation between pathologic, radiographic, and physiologic features in subjects with interstitial lung disease, including IPF and asbestosis, but a direct comparison of structure and function between the two disease entities was not made (18). Cookson et al compared the radiographic features and functional indexes of asbestosis and IPF and found a greater correlation between the transfer factor of the lungs and the radiographic profusion of small parenchymal opacities in subjects with asbestosis, as compared with this correlation in subjects with IPF (after exclusion of subjects with pleural thickening in the asbestosis cases) (19). Similar to us in the present study, Cookson et al found that subjects with IPF had more extensive disease than did those with asbestosis, as measured according to the radiographic extent of small round opacities. However, comparison of neither the quality of fibrosis nor the coexistence of emphysema could be performed in detail with chest radiographs. al-jarad et al compared the distribution and configuration of lung opacities in asbestosis and IPF groups at thin-section CT (1). Ground-glass opacification was more frequent with IPF than with asbestosis (although traction bronchiectasis was not recorded); this finding is similar to our finding of more extensive groundglass opacification with NSIP. al-jarad et al also reported that there was a qualitative impression of greater distortion of the lung architecture owing to fibrosis and emphysema in subjects with IPF as compared with the impression of lung architecture distortion in those with asbestosis, but no quantitative data were given to support this subjective observation. The al-jarad study involved a small number of subjects (18 with IPF and 24 with asbestosis), and only the frequencies of CT features with each condition were analyzed (1). Another important difference is that al-jarad et al concentrated on the frequencies of specific CT features that might allow differentiation between the two conditions instead of quantifying the extent of individual CT patterns as we did in the current study. The quality of fibrosis was more specifically categorized in our study: al Jarad et al grouped subjects into those with a crescentic fine, reticular pattern with small cysts and those with ground-glass opacification. No categories for coarser pattern and traction bronchiectasis existed, and, thus, direct comparisons between the two studies are impossible. Thin-section CT has advantages over other methods of comparing populations Volume 229 Number 3 CT Features of Asbestosis and Idiopathic Pulmonary Fibrosis 735

6 with different interstitial lung diseases (16). Thin-section CT enables a global assessment of the lung, unlike histopathologic analysis of open lung biopsy specimens, in which a relatively small amount of lung parenchyma is sampled. Furthermore, the semiquantitative scoring of disease patterns with CT involves considerably less observer variation than does grading of histopathologic features (20,21). The disadvantage of using pulmonary function indexes to control for the disease extent between these two conditions is that coexisting diseases (eg, pleural thickening with asbestosis) cannot be taken into account. However, there are limitations of using thin-section CT to compare different disease entities that are common to our study and others. These include problems in making histopathologic inferences from CT appearances. For example, in the context of IPF, the histopathologic correlate of ground-glass opacification may represent either partial filling of airspaces with macrophages and alveolar septal inflammation (22) or thickening of alveolar walls owing to fibrosis or edema (23). In a carefully constructed study by Hartley et al in which an objective computer-assisted method was used, the attenuation of the lung parenchyma was examined with thin-section CT in 24 subjects with IPF and in 60 who had been heavily exposed to asbestos (24). Grayscale histograms were obtained in each group, and the subjects with IPF had a flatter gray scale, which was shifted to the right. This indicated increased parenchymal attenuation, which could be analogous to the finer fibrosis seen in the subjects with IPF and the greater proportions of ground-glass opacification seen in those with NSIP in our study. In the study by Hartley et al, textural analysis of the lung parenchyma was not performed, so a direct comparison between their results and ours is difficult (24). In summary, the patients with asbestosis had a coarser pattern of fibrosis than did the subgroup of patients with histopathologically proved NSIP, but there was no statistically significant difference in coarseness between the asbestosis and biopsy-proved UIP groups. Thus, our study findings indicate that asbestosis closely resembles UIP but is strikingly different from NSIP. References 1. al-jarad N, Strickland B, Pearson MC, Rubens MB, Rudd RM. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study. Thorax 1992; 47: Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 1991; 144: Churg A. Non-neoplastic disease caused by asbestos. In: Churg A, Green FHY, eds. Pathology of occupational lung disease. 2nd ed. Baltimore, Md: Williams & Wilkins, 1998; American Thoracic Society. Medical Section of the American Lung Association: the diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986; 134: Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol 1994; 18: Gamsu G, Aberle DR, Lynch D. Computed tomography in the diagnosis of asbestos-related thoracic disease. J Thorac Imaging 1989; 4: Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162: Austin JH, Muller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996; 200: Copley SJ, Wells AU, Rubens MB, et al. Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 2001; 220: Cohen JA. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: Brennan P, Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ 1992; 304: American Thoracic Society and the European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment international consensus statement. Am J Respir Crit Care Med 2000; 161: Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985; 147: Akira M, Yokoyama K, Yamamoto S, et al. Early asbestosis: evaluation with high-resolution CT. Radiology 1991; 178: Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980; 30: Cookson WO, Musk AW, Glancy JJ. Asbestosis and cryptogenic fibrosing alveolitis: a radiological and functional comparison. Aust NZJMed1984; 14: Collins CD, Wells AU, Hansell DM, et al. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol 1994; 49: Cherniak RM, Colby TV, Flint A, et al. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis: the BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1991; 144: Muller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165: Akira M, Yamamoto S, Yokoyama K, et al. Asbestosis: high-resolution CT pathologic correlation. Radiology 1990; 176: Hartley PG, Galvin JR, Hunninghake GW, et al. High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol 1994; 76: Radiology December 2003 Copley et al

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing ASBESTOSIS November 2013 Bruce T. Bishop Lucy L. Brandon Willcox & Savage 440

More information

Is CT screening for asbestos-related diseases rational?

Is CT screening for asbestos-related diseases rational? Is CT screening for asbestos-related diseases rational? Narufumi Suganuma, M.D. 1 Yukinori Kusaka, M.D. 1 Harumi Itoh, M.D. 2 1 Division of Environmental Health, Department of International, Social and

More information

Cystic Lung Diseases. Melissa Price Gillian Lieberman, MD Advanced Radiology Clerkship Beth Israel Deaconess Medical Center November, 2008

Cystic Lung Diseases. Melissa Price Gillian Lieberman, MD Advanced Radiology Clerkship Beth Israel Deaconess Medical Center November, 2008 Cystic Lung Diseases Melissa Price Gillian Lieberman, MD Advanced Radiology Clerkship Beth Israel Deaconess Medical Center November, 2008 How do we define a cyst of the lung? Hansell DM, Bankier AA, MacMahon

More information

Rheumatoid Arthritis related Lung Diseases: CT Findings 1

Rheumatoid Arthritis related Lung Diseases: CT Findings 1 Nobuyuki Tanaka, MD Jeung Sook Kim, MD John D. Newell, MD Kevin K. Brown, MD Carlyne D. Cool, MD Richard Meehan, MD Takuya Emoto, MD Tsuneo Matsumoto, MD David A. Lynch, MB Index terms: Arthritis, rheumatoid,

More information

Clinical, Radiological, and Pathological Investigation of Asbestosis

Clinical, Radiological, and Pathological Investigation of Asbestosis Int. J. Environ. Res. Public Health 2011, 8, 899-912; doi:10.3390/ijerph8030899 OPEN ACCESS Article International Journal of Environmental Research and Public Health ISSN 1660-4601 www.mdpi.com/journal/ijerph

More information

Interstitial lung disease in a rheumatic electrician

Interstitial lung disease in a rheumatic electrician Interstitial lung disease in a rheumatic electrician Case history The case presented here concerns a male, born in 1931, who was an electrician for 34 years. He had frequent and close contact with asbestos,

More information

Pulmonary interstitium. Interstitial Lung Disease. Interstitial lung disease. Interstitial lung disease. Causes.

Pulmonary interstitium. Interstitial Lung Disease. Interstitial lung disease. Interstitial lung disease. Causes. Pulmonary interstitium Interstitial Lung Disease Alveolar lining cells (types 1 and 2) Thin elastin-rich connective component containing capillary blood vessels Interstitial lung disease Increase in interstitial

More information

Multi-slice Helical CT Scanning of the Chest

Multi-slice Helical CT Scanning of the Chest Multi-slice Helical CT Scanning of the Chest Comparison of different low-dose acquisitions Lung cancer is the main cause of deaths due to cancer in human males and the incidence is constantly increasing.

More information

Testimony of. Dr. James Crapo. April 26, 2005

Testimony of. Dr. James Crapo. April 26, 2005 Testimony of Dr. James Crapo April 26, 2005 Written Statement of Dr. James D. Crapo, Professor of Medicine, National Jewish Medical and Research Center and University of Colorado Health Sciences Center

More information

Emphysema Findings Associated with Heavy Asbestos-Exposure in High Resolution Computed Tomography of Finnish Construction Workers

Emphysema Findings Associated with Heavy Asbestos-Exposure in High Resolution Computed Tomography of Finnish Construction Workers J Occup Health 2004; 46: 266 271 Journal of Occupational Health Emphysema Findings Associated with Heavy Asbestos-Exposure in High Resolution Computed Tomography of Finnish Construction Workers Olli HUUSKONEN

More information

Asbestos Disease: An Overview for Clinicians Asbestos Exposure

Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos Asbestos Disease: An Overview for Clinicians Asbestos Exposure Asbestos: A health hazard Exposure to asbestos was a major occupational health hazard in the United States. The first large-scale

More information

Asbestos, Asbestosis, and Lung Cancer

Asbestos, Asbestosis, and Lung Cancer Asbestos, Asbestosis, and Lung Cancer David Weill, M.D. Stanford University Medical Center Stanford, CA David Weill, M.D., is a professor of medicine in the Division of Pulmonary and Critical Care Medicine

More information

Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers

Effects of tobacco smoking on findings in chest computed tomography among asbestos-exposed workers Eur Respir J 2003; 21: 866 871 DOI: 10.1183/09031936.03.00029002 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Effects of tobacco smoking

More information

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.

HEALTH CARE FOR EXPOSURE TO ASBESTOS. 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun. HEALTH CARE FOR PATIENTS WITH EXPOSURE TO ASBESTOS 2010 The SafetyNet Centre for Occupational Health and Safety Research Memorial University www.safetynet.mun.ca HEALTH CARE FOR PATIENTS WITH EXPOSURE

More information

Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers

Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers Abnormalities Consistent with Asbestos-Related Disease Among Long-Term Demolition Workers Stephen M. Levin, M.D. Mount Sinai School of Medicine New York, New York November 1994 The Center to Protect Workers

More information

Role of HRCT in Diagnosis of Asbestos Related Pleuro Pulmonary Disease

Role of HRCT in Diagnosis of Asbestos Related Pleuro Pulmonary Disease Cairo University Role of HRCT in Diagnosis of Asbestos Related Pleuro Pulmonary Disease ESSAY Submitted for partial fulfillment of Master degree in Radio-diagnosis By Rania Adel Abd ElRahem Elghetany (M.B.B.CH.,

More information

Radiological Findings in BO

Radiological Findings in BO Radiological Findings in BO BO-Meeting 2016 Schloss Johannisberg Geisenheim - Rheingau Germany Dr. Simon Martin Department of Diagnostic and Interventional Radiology University Hospital Frankfurt Bronchiolitis

More information

Dermatomyositis and interstitial lung disease. Asmin Tulpule, HMS III November 16, 2009 Core Radiology Clerkship

Dermatomyositis and interstitial lung disease. Asmin Tulpule, HMS III November 16, 2009 Core Radiology Clerkship Dermatomyositis and interstitial lung disease Asmin Tulpule, HMS III November 16, 2009 Core Radiology Clerkship Agenda Presentation of our patient Menu of radiologic tests Basics of interstitial lung disease

More information

Tina Mosaferi, Harvard Medical School Year III Gillian Lieberman, MD

Tina Mosaferi, Harvard Medical School Year III Gillian Lieberman, MD July 2014 Tina Mosaferi, Harvard Medical School Year III 1. Our Patient-Introduction 2. Asbestos Basics 3. Pulmonary Findings Manifestations demonstrated by companion patients 4. Our patient-conclusion

More information

I I A C. INTERSTITIAL FIBROSIS IN COALWORKERS POSITION PAPER 17 THE INDUSTRIAL INJURIES ADVISORY COUNCIL. www.iiac.org.uk

I I A C. INTERSTITIAL FIBROSIS IN COALWORKERS POSITION PAPER 17 THE INDUSTRIAL INJURIES ADVISORY COUNCIL. www.iiac.org.uk I I A C. THE INDUSTRIAL INJURIES ADVISORY COUNCIL POSITION PAPER 17 INTERSTITIAL FIBROSIS IN COALWORKERS www.iiac.org.uk 1 INDUSTRIAL INJURIES ADVISORY COUNCIL PROFESSOR A J NEWMAN TAYLOR, CBE, FRCP, FFOM,

More information

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200 GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung

More information

How To Diagnose And Treat Asbestos Related Diseases

How To Diagnose And Treat Asbestos Related Diseases American Thoracic Society Documents Diagnosis and Initial Management of Nonmalignant Diseases Related to Asbestos This official statement of the American Thoracic Society was adopted by the ATS Board of

More information

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL

SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL SUMMARY OF S.B. 15 ASBESTOS/SILICA LITIGATION REFORM BILL S.B. 15, the asbestos/silica litigation reform bill, distinguishes between the claims of people who are physically impaired or sick due to exposure

More information

Employees Compensation Appeals Board

Employees Compensation Appeals Board U. S. DEPARTMENT OF LABOR Employees Compensation Appeals Board In the Matter of MICHAEL NOMURA, JR. and DEPARTMENT OF THE NAVY, SEA SYSTEMS COMMAND, Vallejo, CA Docket No. 01-1761; Oral Argument Held July

More information

Review Article Imaging Diagnosis of Interstitial Pneumonia with Emphysema (Combined Pulmonary Fibrosis and Emphysema)

Review Article Imaging Diagnosis of Interstitial Pneumonia with Emphysema (Combined Pulmonary Fibrosis and Emphysema) Volume 2012, Article ID 816541, 9 pages doi:10.1155/2012/816541 Review Article Imaging Diagnosis of Interstitial Pneumonia with Emphysema (Combined Pulmonary Fibrosis and Emphysema) Fumikazu Sakai, 1 Junya

More information

Sir William Osler: Listen to the patient; the patient tells you everything.

Sir William Osler: Listen to the patient; the patient tells you everything. Sir William Osler: Listen to the patient; the patient tells you everything. Jean-Martin Charcot: The patient is a liar. Epidemiology of Mesothelioma Jeffrey H. Mandel, MD, MPH Division of Environmental

More information

Cost-effectiveness of Pirfenidone (Esbriet ) for the treatment of Idiopathic Pulmonary Fibrosis.

Cost-effectiveness of Pirfenidone (Esbriet ) for the treatment of Idiopathic Pulmonary Fibrosis. Cost-effectiveness of Pirfenidone (Esbriet ) for the treatment of Idiopathic Pulmonary Fibrosis. March 2013 1. Pirfenidone is indicated in adults for the treatment of mild to moderate Idiopathic Pulmonary

More information

How To Prevent Asbestos Related Diseases

How To Prevent Asbestos Related Diseases BD5.3 Report of Working Groups Elimination of Asbestos-related Diseases ICOH 2012 March 18, 2012 Cancun Report of WG Elimination of Asbestos-related Diseases Dr. Sherson mail to ICOH President of 7 December

More information

Pulmonary Patterns VMA 976

Pulmonary Patterns VMA 976 Pulmonary Patterns VMA 976 PULMONARY PATTERNS Which pulmonary patterns are commonly described in veterinary medicine? PULMONARY PATTERNS Normal Alveolar Interstitial Structured/Nodular Unstructured Bronchial

More information

HANDLING LUNG CANCER CLAIMS

HANDLING LUNG CANCER CLAIMS HANDLING LUNG CANCER CLAIMS JENNIFER S. KILPATRICK SWANSON, MARTIN & BELL, LLP 330 North Wabash Avenue Suite 3300 Chicago, Illinois 60611-3604 (312) 321-3517 (312) 321-0990 jkilpatrick@smbtrials.com 1

More information

Uses and Abuses of Pathology in Asbestos-exposed Populations

Uses and Abuses of Pathology in Asbestos-exposed Populations Uses and Abuses of Pathology in Asbestos-exposed Populations Jerrold L. Abraham, MD Department of Pathology State University of New York Upstate Medical University Syracuse, NY, 13210 USA The term: Asbestosis,

More information

How To Improve Your Ct Image Quality

How To Improve Your Ct Image Quality Translating Protocols Between Scanner Manufacturer and Model Cynthia H. McCollough, PhD, FACR, FAAPM Professor of Radiologic Physics Director, CT Clinical Innovation Center Department of Radiology Mayo

More information

THE EPIDEMIOLOGY OF MESOTHELIOMA IN HISTORICAL CONTEXT

THE EPIDEMIOLOGY OF MESOTHELIOMA IN HISTORICAL CONTEXT occupational safety and health service THE EPIDEMIOLOGY OF MESOTHELIOMA IN HISTORICAL CONTEXT J.C. McDonald, A.D. McDonald OCCUPATIONAL SAFETY & HEALTH SERVICE DEPARTMENT OF LABOUR TE TARI MAHI 1 Emeritus

More information

Restrictive lung diseases

Restrictive lung diseases Restrictive lung diseases Characterized by reduced compliance of the lung. Prominent changes in the interstitium (interstitial lung disease). Important signs and symptoms: - Dyspnea. - Hypoxia. - With

More information

Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis

Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis Andrew Churg, MD Department of Pathology University of British Columbia Vancouver, BC, Canada Techniques,

More information

INTERSTITIAL LUNG DISEASE Paul F. Simonelli, MD, Ph.D.

INTERSTITIAL LUNG DISEASE Paul F. Simonelli, MD, Ph.D. INTERSTITIAL LUNG DISEASE Paul F. Simonelli, MD, Ph.D. Definition: Interstitial lung disease (ILD) refers to a broad range of conditions that have common clinical, physiological, and radiological features.

More information

Expiratory CT: Correlation with Pulmonary Function Tests and Value for Discriminating Lung Diseases

Expiratory CT: Correlation with Pulmonary Function Tests and Value for Discriminating Lung Diseases Original Article Expiratory CT: Correlation with Pulmonary Function Tests and Value for Discriminating Lung Diseases Ertuğrul Mavili 1, Hakan Büyükoğlan 2, Nurdan Bulut Çomu 1, Mustafa Güleç 1 Erciyes

More information

CASE VALUATION MATRIX

CASE VALUATION MATRIX CASE VALUATION MATRIX The Case Valuation Matrix ("Matrix") is designed to approximate historical settlement values in the tort system. To achieve this goal, historical settlement values were evaluated

More information

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL

WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL 2002 ONWSIAT 2116 WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1236/02I [1] This appeal was heard in Kitchener on September 19, 2002, by a Tribunal Panel consisting of: R. Nairn : Vice-Chair,

More information

Instructions for Filing a Claim with the ABB Lummus Global Inc. 524(g) Asbestos PI Trust

Instructions for Filing a Claim with the ABB Lummus Global Inc. 524(g) Asbestos PI Trust Subject: Instructions for Filing a Claim with the ABB Lummus Global Inc. 524(g) Asbestos PI Trust Dear Plaintiff Counsel: The ABB Lummus Global Inc. 524(g) Asbestos PI Trust (the Trust ) was established

More information

All fields on claim form must be completed within the required Sections unless specifically marked as optional on the claim form.

All fields on claim form must be completed within the required Sections unless specifically marked as optional on the claim form. Claim Package Checklist Enhanced Asbestosis (Grade I Non-Malignancy) All fields on claim form must be completed within the required Sections unless specifically marked as optional on the claim form. Enchanced

More information

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF WESTERN ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF WESTERN ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF WESTERN ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX The Case Valuation Matrix ( Matrix ) is designed to approximate historical settlement values in the

More information

Instructions For Filing A Claim With Hercules Chemical Company, Inc. Asbestos Settlement Trust

Instructions For Filing A Claim With Hercules Chemical Company, Inc. Asbestos Settlement Trust Instructions For Filing A Claim With The CLAIM FORM & DECLARATION - HERCULES CHEMICAL COMPANY, INC. ASBESTOS SETTLEMENT TRUST (the Claim Form ), is required of all Injured Parties filing a claim under

More information

Online supplements are not copyedited prior to posting.

Online supplements are not copyedited prior to posting. Functional Impact of a Spectrum of Interstitial Lung Abnormalities in Rheumatoid Arthritis Tracy J. Doyle, MD, MPH; Paul F. Dellaripa, MD; Kerri Batra, MD; Michelle L. Frits, BA; Christine K. Iannaccone,

More information

FIBROGENIC DUST EXPOSURE

FIBROGENIC DUST EXPOSURE FIBROGENIC DUST EXPOSURE (ASBESTOS & SILICA) WORKER S MEDICAL SCREENING GUIDELINE Prepared By Dr. T. D. Redekop Chief Occupational Medical Officer Workplace Safety & Health Division Manitoba Labour & Immigration

More information

Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease

Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed

More information

NOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL

NOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL NOVA SCOTIA WORKERS COMPENSATION APPEALS TRIBUNAL Appellant: [X] (Worker) Participants entitled to respond to this appeal: The Workers Compensation Board of Nova Scotia (Board) APPEAL DECISION Representative:

More information

Apportionment in Asbestos-Related Disease for Purposes of Compensation

Apportionment in Asbestos-Related Disease for Purposes of Compensation Industrial Health 2002, 40, 295 311 Review Article Apportionment in Asbestos-Related Disease for Purposes of Compensation Tee L. GUIDOTTI Department of Public Health Sciences, University of Alberta, Faculty

More information

Criteria for Attributing Lung Cancer to Asbestos Exposure

Criteria for Attributing Lung Cancer to Asbestos Exposure Criteria for Attributing Lung Cancer to Asbestos Exposure Philip T. Cagle, MD The article by Mollo and coworkers 1 examines the criteria for attribution of lung cancers to asbestos exposure, suggesting

More information

The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in:

The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in: Reference Centre for Asbestos Exposure &Health Risk Assessment The AMIANTUS programme of prophylactic medical examinations of the former asbestos workers in: NEONILA SZESZENIA-DĄBROWSKA, BEATA ŚWIŚTKOWSKA,

More information

Interstitial lung disease

Interstitial lung disease Interstitial lung disease William D Travis Abstract Idiopathic interstitial pneumonias represent an important group of interstitial lung diseases, encompassing seven entities: (1) usual interstitial pneumonia

More information

NATIONAL ASBESTOS REGISTERS

NATIONAL ASBESTOS REGISTERS NATIONAL ASBESTOS REGISTERS Annual Report 1995-96 OCCUPATIONAL SAFETY & HEALTH SERVICE LABOUR DEPARTMENT OF TE TARI MAHI Published by the Occupational Safety and Health Service of the Department of Labour

More information

X X X a) perfect linear correlation b) no correlation c) positive correlation (r = 1) (r = 0) (0 < r < 1)

X X X a) perfect linear correlation b) no correlation c) positive correlation (r = 1) (r = 0) (0 < r < 1) CORRELATION AND REGRESSION / 47 CHAPTER EIGHT CORRELATION AND REGRESSION Correlation and regression are statistical methods that are commonly used in the medical literature to compare two or more variables.

More information

International Journal of Case Reports in Medicine

International Journal of Case Reports in Medicine International Journal of Case Reports in Medicine Vol. 2013 (2013), Article ID 409830, 15 minipages. DOI:10.5171/2013.409830 www.ibimapublishing.com Copyright 2013 Andrew Thomas Low, Iain Smith and Simon

More information

Key words: asbestos; asbestosis; chest radiograph; diagnosis; diffusing capacity; lung cancer; rales

Key words: asbestos; asbestosis; chest radiograph; diagnosis; diffusing capacity; lung cancer; rales The Clinical Diagnosis of Asbestosis in This Century Requires More Than a Chest Radiograph* Robert M. Ross, MD, FCCP Asbestosis can cause significant impairment and even death. It is also a well-recognized

More information

Respiratory Conditions in Malaysian Asbestos Cement Workers

Respiratory Conditions in Malaysian Asbestos Cement Workers ORIGINAL ARTICLE Respiratory Conditions in Malaysian Asbestos Cement Workers H H Lim, FAFOM*, KG Rampa!, PhD**, S ]oginder, FRCR***, C M Abu Bakar, MSc****, K H Chan, MBBS*, T N Vivek, MD* Mediviron Consultants

More information

Differentiating between Benign Pleuritis and Mesothelioma by Radiograph using ILO 2000 Classification

Differentiating between Benign Pleuritis and Mesothelioma by Radiograph using ILO 2000 Classification Table of Contents PL-4-13 Narufumi Suganuma Differentiating between Benign Pleuritis and Mesothelioma by Radiograph using ILO 2000 Classification Yukinori Kusaka and Narufumi Suganuma Department of Environmental

More information

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital

Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the

More information

FIRST AMENDED AND COMPLETELY RESTATED PLANT INSULATION COMPANY ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX

FIRST AMENDED AND COMPLETELY RESTATED PLANT INSULATION COMPANY ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX FIRST AMENDED AND COMPLETELY RESTATED PLANT INSULATION COMPANY ASBESTOS SETTLEMENT TRUST CASE VALUATION MATRIX The Case Valuation Matrix ( Matrix ) is designed to approximate Plant s several liability

More information

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX

FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX FIRST AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX The Case Valuation Matrix ( Matrix ) is designed to approximate historical settlement values in the tort system. To achieve

More information

Does referral from an emergency department to an. alcohol treatment center reduce subsequent. emergency room visits in patients with alcohol

Does referral from an emergency department to an. alcohol treatment center reduce subsequent. emergency room visits in patients with alcohol Does referral from an emergency department to an alcohol treatment center reduce subsequent emergency room visits in patients with alcohol intoxication? Robert Sapien, MD Department of Emergency Medicine

More information

by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H.

by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H. OCCUPATIONAL ASBESTOSIS AND RELATED DISEASES by Lee S. Newman, M.D., and Cecile S. Rose, M.D., M.P.H. A 63-year-old man consulted an internist complaining of dyspnea on exertion. He reported the following:

More information

Lung Cancer Causes and Consequences

Lung Cancer Causes and Consequences Lung Cancer Causes and Consequences James D. Crapo, MD University of Colorado Denver Denver, CO crapoj@njc.org James D. Crapo, M.D., is a professor of medicine at the University of Colorado Denver, Division

More information

Health effects of occupational exposure to asbestos dust

Health effects of occupational exposure to asbestos dust Health effects of occupational exposure to asbestos dust Authors: N.Szeszenia-Dąbrowska, U.Wilczyńska The major health effects of workers' exposure to asbestos dust include asbestosis, lung cancer and

More information

PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1. Jonathan C. Daniel 2. Kenneth S.

PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1. Jonathan C. Daniel 2. Kenneth S. PET POSITIVE PLEURAL PLAQUES DECADES AFTER PLEURODESIS: MESOLTHELIOMA? Ellen A. Middleton 1 Jonathan C. Daniel 2 Kenneth S. Knox 1 Kathleen Williams 1 Departments of Medicine 1 and Surgery 2, University

More information

CHAPTER THREE COMMON DESCRIPTIVE STATISTICS COMMON DESCRIPTIVE STATISTICS / 13

CHAPTER THREE COMMON DESCRIPTIVE STATISTICS COMMON DESCRIPTIVE STATISTICS / 13 COMMON DESCRIPTIVE STATISTICS / 13 CHAPTER THREE COMMON DESCRIPTIVE STATISTICS The analysis of data begins with descriptive statistics such as the mean, median, mode, range, standard deviation, variance,

More information

Asbestos Claims Trust Page -1

Asbestos Claims Trust Page -1 Asbestos Claims Trust Page -1 Testimony of Dr. Laura Stewart Welch Medical Director Center to Protect Workers Rights June 4, 2003 Testimony of Laura Welch, MD Medical Director, Center to Protect Workers

More information

Role of Chest CT Scan in Determining Etiology of Primary Spontaneous Pneumothorax

Role of Chest CT Scan in Determining Etiology of Primary Spontaneous Pneumothorax ORIGINAL ARTICLE Role of Chest CT Scan in Determining Etiology of Primary Spontaneous Pneumothorax K.B. Gupta, D.S. Mishra 1, S. Tandon, G. Sindhwani and T. Tanwar Departments of Chest and Tuberculosis

More information

Quantification of Non-Fibrous and Fibrous Particulates in Human Lungs: Twenty Year Update on Pneumoconiosis Database

Quantification of Non-Fibrous and Fibrous Particulates in Human Lungs: Twenty Year Update on Pneumoconiosis Database Ann. occup. Hyg., Vol. 46, Supplement 1, pp. 397 401, 2002 2002 British Occupational Hygiene Society Published by Oxford University Press DOI: 10.1093/annhyg/mef694 Quantification of Non-Fibrous and Fibrous

More information

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,

More information

Asbestos related cancers

Asbestos related cancers New cancer cases 1954-215 in Finland, Men Pukkala et al. 26 Asbestos related cancers Panu Oksa, MD, docent Course on asbestos-related diseases Tartu 4-5.12.26 Asbestos related cancer / FIOH / PO / 1.1.27

More information

How To Understand Aetiology Of Pulmonary Fibrosis

How To Understand Aetiology Of Pulmonary Fibrosis Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiology Maxwell Smith, 1 Mercedes Dalurzo, 2 Prasad Panse, 3 James Parish,

More information

Position Statement from the Irish Thoracic Society on the treatment of Idiopathic Pulmonary Fibrosis

Position Statement from the Irish Thoracic Society on the treatment of Idiopathic Pulmonary Fibrosis BACKGROUND Position Statement from the Irish Thoracic Society on the treatment of Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis (IPF) is a rare, chronic and fatal disease characterised by

More information

Survey of Mesothelioma Associated with Asbestos Exposure in Japan

Survey of Mesothelioma Associated with Asbestos Exposure in Japan The research and development and the dissemination projects related to the 13 fields of occupational injuries and illnesses Survey of Mesothelioma Associated with Asbestos Exposure in Japan Clinical characteristics

More information

Congestive Heart Failure

Congestive Heart Failure William Herring, M.D. 2002 Congestive Heart Failure In Slide Show mode, to advance slides, press spacebar or click left mouse button Congestive Heart Failure Causes of Coronary artery disease Hypertension

More information

Asbestos-related Diseases in the Philippines: The Lung Center of the Philippines Asbestos Screening Program

Asbestos-related Diseases in the Philippines: The Lung Center of the Philippines Asbestos Screening Program REVIEW ARTICLE Asbestos-related Diseases in the Philippines: The Lung Center of the Philippines Asbestos Screening Program Dina V. Diaz 1,2 1 Department of Physiology, College of Medicine, University of

More information

SECOND AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX

SECOND AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX SECOND AMENDMENT TO AND COMPLETE RESTATEMENT OF J.T. THORPE CASE VALUATION MATRIX The Case Valuation Matrix ( Matrix ) is designed to approximate historical settlement values in the tort system. To achieve

More information

Cardiac Masses and Tumors

Cardiac Masses and Tumors Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:

More information

The CARET Asbestos-Exposed Cohort: Baseline Characteristics and Comparison to Other Asbestos-Exposed Cohorts

The CARET Asbestos-Exposed Cohort: Baseline Characteristics and Comparison to Other Asbestos-Exposed Cohorts AMERICAN JOURNAL OF INDUSTRIAL MEDICINE 32:573 581 (1997) The CARET Asbestos-Exposed Cohort: Baseline Characteristics and Comparison to Other Asbestos-Exposed Cohorts Scott Barnhart, MD, MPH, 1 * James

More information

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST

INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST INSTRUCTIONS FOR FILING A CLAIM WITH THE CELOTEX ASBESTOS SETTLEMENT TRUST The Celotex Asbestos Settlement Trust (Celotex Trust) was established as a result of the bankruptcy of the Celotex Corporation

More information

Ventilation Perfusion Relationships

Ventilation Perfusion Relationships Ventilation Perfusion Relationships VENTILATION PERFUSION RATIO Ideally, each alveolus in the lungs would receive the same amount of ventilation and pulmonary capillary blood flow (perfusion). In reality,

More information

(Sample from The Altman Group Ballot Archive) Ballot No. 1 - Individual Ballot for Class 7 Direct Asbestos PI Claims

(Sample from The Altman Group Ballot Archive) Ballot No. 1 - Individual Ballot for Class 7 Direct Asbestos PI Claims UNITED STATES BANKRUPTCY COURT DISTRICT OF DELAWARE In re USG CORPORATION, a Delaware corporation, et al., 1 Debtors. Chapter 11 Jointly Administered Case No. 01-2094 (JKF) INDIVIDUAL BALLOT FOR ACCEPTING

More information

Primary -Benign - Malignant Secondary

Primary -Benign - Malignant Secondary TUMOURS OF THE LUNG Primary -Benign - Malignant Secondary The incidence of lung cancer has been increasing almost logarithmically and is now reaching epidemic levels. The overall cure rate is very low

More information

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine and systemic chemotherapy in malignant pleural mesothelioma. A 10-year experience. L Lang-Lazdunski, A Bille, S Marshall, R Lal,

More information

Asbestos: The Range of Its Ill-Effects. Ezra Cohen, MS III Dr. Gillian Lieberman, MD Core Radiology Clerkship, BIDMC April 16 th, 2010

Asbestos: The Range of Its Ill-Effects. Ezra Cohen, MS III Dr. Gillian Lieberman, MD Core Radiology Clerkship, BIDMC April 16 th, 2010 Asbestos: The Range of Its Ill-Effects Ezra Cohen, MS III Dr. Gillian Lieberman, MD Core Radiology Clerkship, BIDMC April 16 th, 2010 Outline of Presentation Patient Presentation Anatomy Defining the disease

More information

SUPPLEMENTAL NOTE ON SENATE BILL NO. 592

SUPPLEMENTAL NOTE ON SENATE BILL NO. 592 SESSION OF 2006 SUPPLEMENTAL NOTE ON SENATE BILL NO. 592 As Amended by Senate Committee on Financial Institutions and Insurance Brief* SB 592 would enact new law, the Asbestos Compensation Fairness Act.

More information

Organizing Your Approach to a Data Analysis

Organizing Your Approach to a Data Analysis Biost/Stat 578 B: Data Analysis Emerson, September 29, 2003 Handout #1 Organizing Your Approach to a Data Analysis The general theme should be to maximize thinking about the data analysis and to minimize

More information

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis What is Idiopathic Pulmonary Fibrosis? Idiopathic pulmonary fibrosis (IPF) is a condition that causes persistent and progressive scarring of the tiny air sacs (alveoli) in

More information

Patient sample criteria for the OPEIR Measures Group are all patients regardless of age, that have a specific CT procedure performed:

Patient sample criteria for the OPEIR Measures Group are all patients regardless of age, that have a specific CT procedure performed: OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: 2016 PQRS MEASURES IN OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES

More information

Testimony of. Laura Welch, M.D. Medical Director Center to Protect Workers Rights November 17, 2005

Testimony of. Laura Welch, M.D. Medical Director Center to Protect Workers Rights November 17, 2005 Testimony of Laura Welch, M.D. Medical Director Center to Protect Workers Rights November 17, 2005 Testimony of Laura Welch, MD Medical Director, Center to Protect Workers Rights On Asbestos Related Diseases

More information

PARTICLE SIZE AND CHEMISTRY:

PARTICLE SIZE AND CHEMISTRY: Pneumoconioses LW/Please note: This information is additional to Davidson s Principles and Practice of Medicine. /Hierdie inligting is aanvullend tot Davidson s Principles and Practice of Medicine. Pneumoconioses

More information

II. DISTRIBUTIONS distribution normal distribution. standard scores

II. DISTRIBUTIONS distribution normal distribution. standard scores Appendix D Basic Measurement And Statistics The following information was developed by Steven Rothke, PhD, Department of Psychology, Rehabilitation Institute of Chicago (RIC) and expanded by Mary F. Schmidt,

More information

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003 ASBESTOS Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003 Asbestosis Asbestosis is a model for other dust diseases as well as

More information

OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS FOR MEASURES GROUPS:

OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS FOR MEASURES GROUPS: OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN OPTIMIZING PATIENT EXPOSURE TO IONIZING RADIATION (OPEIR) MEASURES

More information

Toxicity of Amphibole Asbestos

Toxicity of Amphibole Asbestos Toxicity of Amphibole Asbestos Disclaimer: The material presented in these slides has been reviewed by the U.S. EPA and approved for presentation. Approval does not signify that the contents necessarily

More information

Occupational Lung Disease. SS Visser Internal Medicine UP

Occupational Lung Disease. SS Visser Internal Medicine UP Occupational Lung Disease SS Visser Internal Medicine UP Classification Anorganic ( mineral ) dust/pneumoconiosis Fibrogenic - silica, asbestos, talc, silicates Non-fibrogenic - Fe, barium, tin Immunologic/Pharmcologic

More information

Since the 1970s, governmental and nongovernmental. Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA

Since the 1970s, governmental and nongovernmental. Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA Eur Respir J 2011; 38: 376 383 DOI: 10.1183/09031936.00050210 CopyrightßERS 2011 Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA D. Weill*, G. Dhillon*, L.

More information

UKRC 2015 Dr Michael Sproule Glasgow

UKRC 2015 Dr Michael Sproule Glasgow UKRC 2015 Dr Michael Sproule Glasgow Radiology of Asbestos Related Lung Disease General term given to a group of fibrous minerals containing silica and a variety of other elements. Asbestos: Derived

More information

Comparison of Disease Progression and Mortality of Connective Tissue Disease-Related Interstitial Lung Disease and Idiopathic Interstitial Pneumonia

Comparison of Disease Progression and Mortality of Connective Tissue Disease-Related Interstitial Lung Disease and Idiopathic Interstitial Pneumonia Arthritis & Rheumatism (Arthritis Care & Research) Vol. 53, No. 4, August 15, 2005, pp 549 557 DOI 10.1002/art.21322 2005, American College of Rheumatology ORIGINAL ARTICLE Comparison of Disease Progression

More information